Recently diagnosed with HIV? Click here

PHAEDRA

Clinical trial • Fully enrolled • 11 May 2007
This trial is fully enrolled. This means that all of the available places on the trial have been filled. You cannot enrol in this trial.

About this trial

PHAEDRA is an ongoing study following a group of people ('cohortIn epidemiology, a group of individuals with some characteristics in common. A cohort study is a special kind of clinical trial which looks at a treatment or treatment strategy in a cohort of people.') who were enrolledThe act of signing up participants into a study. Generally this process involves evaluating a participant with respect to the eligibility criteria of the study and going through the informed consent process. in the very early period following seroconversion ('primary HIV infection'). The study aim is to explore and characterise some of the immune system responses to HIV in the period following infection, to look at the effects of treatment and to identify any particular factors that may influence the progression of HIV disease. The study will also monitor the transmission of drug-resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant. HIV.

There is no particular treatment regimen associated with this study. People are free to make their own treatment decisions within this study. People in the study are followed over time, and undergo routine annual collection of medical information including viral loadA measurement of the quantity of HIV RNA in the blood. Viral load blood test results are expressed as the number of copies (of HIV) per milliliter of blood plasma., CD4 count, and other information, such as any illnesses experienced.

Background information

Many of the PHAEDRA cohortIn epidemiology, a group of individuals with some characteristics in common. A cohort study is a special kind of clinical trial which looks at a treatment or treatment strategy in a cohort of people. have rolled over into a separate international primary infection natural history studyStudy of the natural development of something (such as an organism or a disease) over a period of time, with or without the intervention of treatment. called CORE01.

Official title:A prospective cohort of individuals with primary HIV infection to determine immunological, virological and therapeutic factors related to disease progression
What is this trial studying?Other
Start date:September 2002

This may be the proposed or expected start date for trials which have not yet started.

Links to further information:
Tags:primary HIV infection

Who can enrol in this trial?

You may be eligible to participate in this trial if you meet the following criteria:

  • At least 18 years old
  • Recently been infected with HIV, or undergoing seroconversion

This is a summary of key inclusion and exclusion criteria for this trial. There may be other criteria which may exclude some people from participation in this trial. Some laboratory tests may also be required. Consult your doctor, or view the trial protocol or informed consent documentation to see the full range of exclusion and inclusion criteria.

Disclaimer

While NAPWA has taken every care to compile the information on this page and to keep it up-to-date, we cannot guarantee its correctness and completeness.

  • Before making the decision to participate in any clinical research, read our background information.
  • Email NAPWA if you have any questions or comments about this trial
Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

This Clinical trial was first published on 11 May 2007 — more than four years ago.

While the content of this clinical trial was checked for accuracy at the time of publication, NAPWA recommends checking to determine whether the information is the most up-to-date available, especially when making decisions which may affect your health.

This article may contain medical information. NAPWA makes every reasonable effort to ensure the information on this website is accurate, reliable and up-to-date, including obtaining technical reviews by medically-qualified reviewers, however the authors of information on this website are not qualified to give medical advice, except where explicitly stated.

The content of this website is intended to support, not replace, the relationship between people living with HIV/AIDS and their medical advisers, and is not intended as a substitute for medical advice.

Website links

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.

more